Cargando…

Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access

BACKGROUND AND AIM: Direct-acting antiviral (DAA) treatments became available for all people living with hepatitis C virus (HCV) in Australia in March 2016. We assess variations in treatment rates and prescribing patterns across Australia's 338 Statistical Area 3 (SA3) geographical units. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scott, Nick, Hainsworth, Samuel W, Sacks-Davis, Rachel, Pedrana, Alisa, Doyle, Joseph, Wade, Amanda, Hellard, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mediscript Ltd 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892674/ https://www.ncbi.nlm.nih.gov/pubmed/29682303

Ejemplares similares

Australia needs to increase testing to achieve hepatitis C elimination
por: Scott, Nick, et al.
Publicado: (2020)

Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study
por: Scott, Dr Nick, et al.
Publicado: (2021)

Affordable treatment and political commitment are crucial to eliminate hepatitis C globally
por: Hellard, Margaret, et al.
Publicado: (2021)

Hepatitis C risk perceptions and attitudes towards reinfection among HIV‐diagnosed gay and bisexual men in Melbourne, Australia
por: Schroeder, Sophia E, et al.
Publicado: (2019)

Trial and error: evaluating and refining a community model of HIV testing in Australia
por: Ryan, Kathleen E., et al.
Publicado: (2017)

Assessment of service refinement and its impact on repeat HIV testing by client's access to Australia's universal healthcare system: a retrospective cohort study
por: Ryan, Kathleen E, et al.
Publicado: (2019)

The use of social networking platforms for sexual health promotion: identifying key strategies for successful user engagement
por: Veale, Hilary J, et al.
Publicado: (2015)

Pathways to ensure universal and affordable access to hepatitis C treatment
por: Douglass, Caitlin H., et al.
Publicado: (2018)

Assessing the feasibility, acceptability and impacts of an education program on hepatitis B testing uptake among ethnic Chinese in Australia: results of a randomised controlled pilot study
por: Xiao, Yinzong, et al.
Publicado: (2021)

Intent to Be Vaccinated against COVID-19 in Victoria, Australia
por: Heath, Katherine, et al.
Publicado: (2022)

Modelling the impact of relaxing COVID‐19 control measures during a period of low viral transmission
por: Scott, Nick, et al.
Publicado: (2020)

Hepatitis C virus notification rates in Australia are highest in socioeconomically disadvantaged areas
por: Hainsworth, Samuel W., et al.
Publicado: (2018)

Metagenomics: Unrestricted access to microbial communities
por: Allan, Elaine
Publicado: (2014)

Unrestricted access to medical research articles
Publicado: (2015)

Unrestricted access to medical case reports
por: Chapman, Pete
Publicado: (2015)

Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus
por: Saeed, Sahar, et al.
Publicado: (2020)

Letter to the Editor: Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective
por: Harney, Brendan, et al.
Publicado: (2020)

A systematic examination of the use of Online social networking sites for sexual health promotion
por: Gold, Judy, et al.
Publicado: (2011)

Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019
por: Lee Wilkinson, Anna, et al.
Publicado: (2021)

Does sexuality matter? A cross-sectional study of drug use, social injecting, and access to injection-specific care among men who inject drugs in Melbourne, Australia
por: Schroeder, Sophia E., et al.
Publicado: (2023)

COVID-19 epidemic modelling for policy decision support in Victoria, Australia 2020–2021
por: Scott, Nick, et al.
Publicado: (2023)

Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence
por: Higgs, Peter, et al.
Publicado: (2011)

Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 – CORRIGENDUM
por: Lee Wilkinson, Anna, et al.
Publicado: (2022)

A systematic review of community based hepatitis C treatment
por: Wade, Amanda J., et al.
Publicado: (2016)

The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia
por: Gunn, Jack, et al.
Publicado: (2023)

Keeping kids in school: modelling school-based testing and quarantine strategies during the COVID-19 pandemic in Australia
por: Abeysuriya, Romesh G., et al.
Publicado: (2023)

Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study)
por: O’Keefe, Daniel, et al.
Publicado: (2022)

Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol
por: Marukutira, Tafireyi, et al.
Publicado: (2022)

Estimating the proportion of Victorians infected with COVID-19 during the Omicron BA.1 epidemic wave of January 2022 in Australia
por: Altermatt, Aimée, et al.
Publicado: (2023)

Quarantine preparedness – the missing factor in COVID-19 behaviour change? Qualitative insights from Australia
por: Davis, Angela, et al.
Publicado: (2022)

Linkage and retention in HCV care for HIV‐infected populations: early data from the DAA era
por: Sacks‐Davis, Rachel, et al.
Publicado: (2018)

Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients
por: Draper, Bridget, et al.
Publicado: (2022)

Effects of unrestricted access to flash glucose monitoring in type 1 diabetes
por: Hansen, Klavs Würgler
Publicado: (2020)

Patients’ access to and acceptance of community-based hepatitis C testing and treatment in Myanmar: A mixed-method study
por: Yee, Win Lei, et al.
Publicado: (2023)

Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings: a mixed-methods evaluation of the Tasmanian Eliminate Hepatitis C Australia Outreach Project, 2020–2022
por: Dawe, Joshua, et al.
Publicado: (2023)

Impact of COVID‐19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs
por: Traeger, Michael W., et al.
Publicado: (2022)

Description of social contacts among student cases of pandemic influenza during the containment phase, Melbourne, Australia, 2009
por: van Gemert, Caroline, et al.
Publicado: (2018)

Eradication of hepatitis C infection: The importance of targeting people who inject drugs
por: Hellard, Margaret, et al.
Publicado: (2014)

High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
por: Sacks-Davis, Rachel, et al.
Publicado: (2013)

A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C
por: Ramsay, Jessica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ht6se2dmrg54n2r4uras67hhqd